Alaunos Therapeutics, Inc. Common Stock (TCRT) is a publicly traded Healthcare sector company. As of August 14, 2026, TCRT trades at $1.99 with a market cap of $4.88M and a P/E ratio of -0.92. TCRT moved +0.25% today. Year to date, TCRT is -39.33%; over the trailing twelve months it is -16.74%. Its 52-week range spans $1.31 to $6.20. Rallies surfaces TCRT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Alaunos Therapeutics, Inc. Common Stock (TCRT) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. TCRT moved +0.25% today.
| Metric | Value |
|---|---|
| Price | $1.99 |
| Market Cap | $4.88M |
| P/E Ratio | -0.92 |
| EPS | $-2.20 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.20 |
| 52-Week Low | $1.31 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $5.00K |
| Net Income | $-4.18M |
| Gross Margin | 0.00% |
TCRT analyst coverage data. Average price target: $0.00.